Campbell & CO Investment Adviser LLC Pacific Biosciences Of California, Inc. Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.52 - $9.59 $157,833 - $430,006	44,839 Added 113.19%	84,454 $316,000
Q4 2023 Feb 13, 2024	SELL	$5.97 - $10.36 $70,786 - $122,838	-11,857 Reduced 23.04%	39,615 $388,000
Q3 2023 Nov 08, 2023	BUY	$8.23 - $13.93 $423,614 - $717,004	51,472 New	51,472 $429,000
Q2 2022 Aug 09, 2022	SELL	$4.02 - $10.43 $52,967 - $137,425	-13,176 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$8.43 - $20.9 $111,073 - $275,378	13,176 New	13,176 $120,000
Q3 2021 Nov 10, 2021	SELL	$24.86 - $35.02 $248,600 - $350,200	-10,000 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$22.3 - $36.02 $223,000 - $360,200	10,000 New	10,000 $350,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.